Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma

OBJECTIVES: 2-deoxy-2[(18)F]Fluoro-d-glucose (FDG) PET-CT has an emerging role in assessing response to neoadjuvant therapy in oesophageal cancer. This study evaluated FDG PET-CT in predicting pathological tumour response (pTR), pathological nodal response (pNR) and survival. METHODS: Cohort study o...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Jonathan L., Subesinghe, Manil, Santaolalla, Aida, Green, Michael, Deere, Harriet, Van Hemelrijck, Mieke, Lagergren, Jesper, Chicklore, Sugama, Maisey, Nick, Gossage, James A., Kelly, Mark, Baker, Cara R., Davies, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Gastrointestinal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121512/
https://www.ncbi.nlm.nih.gov/pubmed/36920518
http://dx.doi.org/10.1007/s00330-023-09482-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121512/
https://www.ncbi.nlm.nih.gov/pubmed/36920518
http://dx.doi.org/10.1007/s00330-023-09482-7

Ejemplares similares